Uncategorized
Global Proliferative Diabetic Retinopathy (PDR) Therapeutics Pipeline Report, H1 2017 – Review of 8 Companies & Drug Profiles – Research and Markets
DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Proliferative Diabetic Retinopathy (PDR) - Pipeline Review, H1 2017" report to their offering. Pharmaceutical and Healthcare latest pipeline guide Proliferative Diabetic Retinopathy (PDR) - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Proliferative Diabetic Retinopathy (PDR) (Metabolic Disorders), complete with analysis by stage of development, drug target,